Mon.Sep 09, 2024

article thumbnail

New AI can ID brain patterns related to specific behavior

Science Daily: Pharmacology News

Scientists have developed a new AI algorithm that can separate brain patterns related to a particular behavior. This work promises to improve brain-computer interfaces and aid with the discovery of new brain patterns.

361
361
article thumbnail

Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection

Drugs.com

MONDAY, Sept. 9, 2024 -- A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates.The new formulation encases semaglutide in.

279
279
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Artificial muscles propel a robotic leg to walk and jump

Science Daily: Pharmacology News

Researchers have developed a robotic leg with artificial muscles. Inspired by living creatures, it jumps across different terrains in an agile and energy-efficient manner.

Research 345
article thumbnail

Flying Could Upset Insulin Pump Function for Type 1 Diabetics

Drugs.com

MONDAY, Sept. 9, 2024 -- Diabetics who fly with an insulin pump could find themselves with lower-than-normal blood sugar levels, a new study says.Altitude appears to affect the ability of insulin pumps to deliver a steady supply of the hormone.

264
264
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Formation of super-Earths is limited near metal-poor stars

Science Daily: Pharmacology News

In a new study, astronomers report novel evidence regarding the limits of planet formation, finding that after a certain point, planets larger than Earth have difficulty forming near low-metallicity stars.

309
309

More Trending

article thumbnail

New research sinks an old theory for the doldrums, a low-wind equatorial region that stranded sailors for centuries

Science Daily: Pharmacology News

During the Age of Sail, sailors riding the trade winds past the equator dreaded becoming stranded in the doldrums, a meteorologically distinct region in the deep tropics. For at least a century, scientists have thought that the doldrums' lack of wind was caused by converging and rising air masses. Now, new research suggests that the opposite may be true.

Research 309
article thumbnail

Vaping Could Make Young Adults Physically Weaker

Drugs.com

MONDAY, Sept. 9, 2024 -- In exercise bike tests, twentysomethings who'd been vaping for at least two years had much lower exercise capacity than those who didn't, and the losses were equal to those of folks who'd spent a similar amount of time.

246
246
article thumbnail

Extreme weather to strengthen rapidly over next two decades

Science Daily: Pharmacology News

The study shows how global warming can combine with normal variations in the weather to produce decade-long periods of very rapid changes in both extreme temperatures and rainfall.

305
305
article thumbnail

He's Doing Great a Year After World's First Eye and Partial Face Transplant

Drugs.com

Key TakeawaysA man who received the world’s first combined whole-eye and partial face transplant is doing wellHis body has not rejected either his new face of his new left eyeHowever, vision has not returned in the donated eyeMONDAY, Sept. 9, 2024 -.

246
246
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Giant fanged frog went unrecognized in Philippines because it was nearly identical to even larger species

Science Daily: Pharmacology News

Researchers published findings describing a new species of fanged frog, named Limnonectes cassiopeia, from the Philippine island of Luzon.

Research 286
article thumbnail

Salmonella Tied to Eggs Sickens 65 in Nine States

Drugs.com

MONDAY, Sept. 9, 2024 -- At least 65 people in nine states have been sickened in a salmonella outbreak linked to recalled eggs, U.S. health officials report."The nine states include the three states where the eggs were sold -- Illinois, Michigan.

189
189
article thumbnail

Early study data puts Terns among obesity drug contenders

BioPharma Drive: Drug Pricing

A once-daily pill the biotech is developing helped some people with obesity lose more than 5% of their weight in a month, spurring a stock bump and plans to bring the drug into further testing.

Drugs 176
article thumbnail

Princess Kate Says She Has Completed Chemo, Resuming 'Light' Duties

Drugs.com

MONDAY, Sept. 9 , 2024 -- Catherine, Princess of Wales, has announced that she has completed chemotherapy for an unnamed form of cancer.The princess, 42, made the announcement in a video message posted by Kensington Palace on Monday. She said she.

130
130
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Relay breast cancer drug shows potential in early trial

BioPharma Drive: Drug Pricing

Results from a small study suggest Relay's drug could avoid some of the toxicity associated with existing PI3Ka inhibitors like Novartis' Piqray.

Trials 176
article thumbnail

Men Often Confused About Prostate Cancer Screening, Survey Shows

Drugs.com

MONDAY, Sept. 9, 2024 -- A new survey finds the majority of American men believe the first step in prostate cancer screening is an invasive rectal exam by their doctor.That's not true, but mistaken beliefs like these could keep men from getting.

130
130
article thumbnail

Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease

BioPharma Drive: Drug Pricing

The startup believes T cell engagers, rather than cell therapies, will prove the “right horse to bet on” in the race to develop new inflammatory disease treatments, its CEO said.

Disease 176
article thumbnail

Moms, Don't Meddle With Your Kids' Friends: It'll Only Make Things Worse

Drugs.com

MONDAY, Sept. 9, 2024 -- Meddling moms who try to prohibit their kids’ friendships with troublemakers will only make things worse, a new study says.Limiting contact with a friend who appears to be a bad influence tends to exacerbate the behavior p.

130
130
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Accelerating Alzheimer’s therapy innovation: A new horizon in blood-based biomarkers

BioPharma Drive: Drug Pricing

The escalating global challenge of Alzheimer's Disease (AD) demands new approaches to detection, diagnosis and treatment.

Therapies 176
article thumbnail

Obesity Raises Risk of Severe Infection, Especially in People With Diabetes

Drugs.com

MONDAY, Sept. 9, 2024 -- Losing weight can help a person with obesity -- especially those with diabetes -- fend off serious infections, new data shows.It's an important finding, since "up to one in three hospitalizations in people with diabetes are.

Hospitals 130
article thumbnail

Content Hub: Data Model Simplified

Perficient: Drug Development

Sitecore Content Hub is a world-class platform for centralizing and managing content across various channels. It helps businesses organize and streamline often chaotic, messy content operations. It does this by providing an architecture or schema for content and its interconnections. A schema defines how different types of assets are structured, organized, related to each other.

Marketing 105
article thumbnail

Missouri Patient Hospitalized With Bird Flu Had No Known Contact With Animals

Drugs.com

MONDAY, Sept. 9 , 2024 -- A case of bird flu has been confirmed in a Missouri resident who had no known contact with dairy cows, poultry or wild birds, U.S. health officials report."The patient, who was hospitalized, had underlying medical.

Hospitals 130
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Exploring Approaches to Keep an AI-Enabled Workplace Safe for Workers

NIOSH Science Blog: Drugs

Artificial intelligence (AI)—the field of computer science that designs machines to perform tasks that typically require human intelligence—has seen rapid advances leading to cutting‐edge innovations in language, vision, reasoning, and human‐machine collaboration across industries, economies, and labor markets.[1] [2] In the workplace, the adoption of AI technologies can result in a broad range of hazards and risks to workers, as illustrated by the recent growth in industrial robotics and algori

article thumbnail

Arbemnifosbuvir, AT-752, PD160572

New Drug Approvals

Arbemnifosbuvir, AT-752, 1998705-63-7, PD160572 E9V7VHK36U INN 12706 C 24 H 33 FN 7 O 7 P 581.5 g/mol SYN propan-2-yl (2 S )-2-[[[(2 R ,3 R ,4 R ,5 R )-5-[2-amino-6-(methylamino)purin-9-yl]-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate L-ALANINE, N-((P(R),2’R)-2-AMINO-2′-DEOXY-2′-FLUORO-N,2′-DIMETHYL-P-PHENYL-5′ -ADENYLYL)-, 1-METHYLETHYL ESTER N-((P(R),2’R)-2-AMINO-2′-DEOXY-2′-FLUORO-N,2′-DIMETHYL-P-PHENYL

article thumbnail

’1104: tackling the root cause of allergic disease

Drug Target Review

Could you detail how ‘1104, derived from Mycobacterium tuberculosis Chaperonin 60.1, functions to reset the immune system and potentially provide remission for allergic diseases? ‘1104 acts upstream in the inflammatory response, targeting one of the first key players: antigen-presenting cells (APCs). In allergic diseases, APCs identify and present unknown antigens to the immune system.

Disease 64
article thumbnail

Zelicapavir

New Drug Approvals

Zelicapavir, Enanta Pharmaceuticals Alternative Names: EDP-938; EP 023938 cas 2070852-76-3 RSV-IN-7 549.5 g/mol, C 27 H 22 F 3 N 7 O 3 UNII U4OI721DMD (3 S )-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)pyridin-2-yl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one SYN New England Journal of Medicine (2022), 386(7), 655-666 WO2022157327 WO2018152413 WO2019067864 WO2017015449 PATENT WO2018152413 [link] Step 5 : ( < S f )-3-((5-(3-morpholino-5-(trifluoromethyl)pyridin-2-y

article thumbnail

CDMO Trends for the Next Decade

Drug Patent Watch

The contract development and manufacturing organization (CDMO) industry is poised to continue its rapid growth and evolution over the next decade. As biopharma companies increasingly rely on CDMOs to develop and manufacture complex therapeutics, several key trends are shaping the future of the industry.

59
article thumbnail

Upcoming Changes for Oracle EPM Cloud Customers

Perficient: Drug Development

Oracle routinely announces significant future changes for EPM customers in each month’s cloud readiness documentation. If you’re not aware, Oracle EPM cloud updates are published monthly. If you read the details within the ‘Important Actions and Considerations’ section (located at the bottom of each readiness release), you will notice several very interesting announcements that we’ve highlighted below.

52
article thumbnail

Drug Patent Expirations for the Week of September 8, 2024

Drug Patent Watch

ORILISSA (elagolix sodium) Abbvie Patent: 7,056,927 Expiration: Sep 10, 2024 See More … Source

Drugs 52
article thumbnail

When Health Stakeholders Collaborate Better, Patients Win

Fierce BioTech

When Health Stakeholders Collaborate Better, Patients Win When different healthcare stakeholders have goals that align, patients can stand to benefit. Access this resource today to discover what life sciences organizations can do to help get critical conversations started. This valuable guide will help in developing a roadmap for better, more productive healthcare stakeholder partnerships that can improve patient health and close gaps in care. tharilall Mon, 09/09/2024 - 16:46 When different hea

Science 52